iRhythm Holdings, Inc. (IRTC)
128.48
-5.27
(-3.94%)
USD |
NASDAQ |
Mar 02, 16:00
128.48
0.00 (0.00%)
After-Hours: 18:09
iRhythm Holdings Research and Development Expense (Annual) : 84.61M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Tandem Diabetes Care, Inc. | 174.84M |
| Alphatec Holdings, Inc. | 76.27M |
| AtriCure, Inc. | 90.17M |
| Baxter International, Inc. | 503.00M |
| ICU Medical, Inc. | 87.50M |